Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine

Zugriffe
Evaluating ...1328

Gesamtzugriffe pro Monat

August 2025September 2025Oktober 2025November 2025Dezember 2025Januar 2026Februar 2026
Evaluating ...21351418185

Dateiabrufe

Zugriffe
21VmhogDXFlrE.pdf679